Japan greenlights Novavax vaccine, shots to start as early as May

Japan's health ministry Tuesday approved the use of a COVID-19 vaccine developed by U.S. biotechnology firm Novavax Inc., with deliveries of the drug to local governments expected to start in late May, and shots might also begin that month.The approval by the Ministry of Health, Labor and Welfare marks the fourth vaccine to be greenlit for use in Japan and will be produced domestically by medical giant Takeda Pharmaceutical Co., which has been given the technology to manufacture the drug.Novavax's vaccine will be the first protein-based one, intended for patients who could not use existing …READ FULL ARTICLE